Neuroone Medical Technologies (NMTC) Gross Profit (2011 - 2026)

Neuroone Medical Technologies (NMTC) has reported Gross Profit for 11 consecutive years, with $1.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit rose 29.27% year-over-year to $1.2 million; the trailing twelve-month figure through Jun 2026 stood at $5.3 million (up 40.37% YoY), and the FY2025 full-year result was $5.1 million, up 376.2% from the prior year.
• Gross Profit grew to $1.2 million in Q2 2026 per NMTC's latest filing, from $990264.0 in the prior quarter.
• Across five years, Gross Profit topped out at $1.9 million in Q4 2024 and bottomed at -$36223.0 in Q1 2022.
• Historically, Gross Profit has averaged $575588.5 across 5 years, with a median of $274093.0 in 2023.
• The sharpest annual moves came in 2022 and 2023: Gross Profit slumped 71.49% in 2022, then soared 3899.56% in 2023.
• Over 5 years, Gross Profit stood at -$12307.0 in 2022, then jumped by 2263.92% to $266314.0 in 2023, then soared by 623.54% to $1.9 million in 2024, then decreased by 18.63% to $1.6 million in 2025, then declined by 24.57% to $1.2 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $1.2 million, $990264.0, and $1.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.